NXL GoodMoat Verdict
Full signal breakdown coming soon. Use the X-Ray tool for a detailed analysis.
Nexalin Technology Inc
Exchange: NASDAQSector: HealthcareIndustry: Medical Devices
Nexalin designs and develops innovative neurostimulation products to uniquely help combat the ongoing global mental health epidemic. All of Nexalin’s products are believed to be non-invasive and undetectable to the human body and are developed to provide relief to those afflicted with mental health issues. Nexalin utilizes bioelectronic medical technology to treat mental health issues. Nexalin believes its neurostimulation medical devices can penetrate structures deep in the mid-brain that are associated with mental health disorders. Nexalin believes the deeper-penetrating waveform in its next-generation devices will generate enhanced patient response without any adverse side effects. The Nexalin Gen-2 15 milliamp neurostimulation device has been approved in China, Brazil, and Oman.
Did you know?
Holds 654783.0x more cash than debt — a strong balance sheet.
Current Price
$0.38
+0.03%GoodMoat Value
$0.08
79.4% overvaluedProfile
Valuation (TTM)
Market Cap$7.10M
P/E-0.86
EV—
P/B1.89
Shares Out18.65M
P/Sales23.52
Revenue$301647.00
EV/EBITDA—
Nexalin Technology Inc (NXL) Quality Analysis
NXL Profitability
Profitability trend analysis coming soon
NXL Growth
Growth trend analysis coming soon
NXL Financial Health
Financial health indicators coming soon
NXL Quality & Fundamental Analysis
Nexalin Technology Inc (NXL) is a Healthcare company in the Medical Devices industry, listed on NASDAQ. This quality analysis page evaluates Nexalin Technology Inc's financial health using the Piotroski F-Score methodology, profitability ratios, growth trajectory, and balance sheet strength.
Nexalin Technology Inc has a Piotroski F-Score of N/A out of 9, measuring profitability, leverage, and operating efficiency. The company operates with a profit margin of -2725.76% and a return on equity (ROE) of -219.38%. Return on assets (ROA) stands at -177.38%.
with a current ratio of 4.85. Operating margin is -2781.69%.
GoodMoat's quality analysis uses AI-powered insights to evaluate whether Nexalin Technology Inc is a fundamentally sound investment. The GoodMoat Verdict synthesizes profitability, growth, and financial health scores into a clear investment quality rating. Use these metrics alongside valuation tools like the DCF calculator and fair value models to make informed investment decisions.